Skip to main content
Journal cover image

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.

Publication ,  Journal Article
International MG/COVID-19 Working Group, ; Jacob, S; Muppidi, S; Guidon, A; Guptill, J; Hehir, M; Howard, JF; Illa, I; Mantegazza, R; Murai, H ...
Published in: J Neurol Sci
May 15, 2020

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Neurol Sci

DOI

EISSN

1878-5883

Publication Date

May 15, 2020

Volume

412

Start / End Page

116803

Location

Netherlands

Related Subject Headings

  • Vaccines
  • SARS-CoV-2
  • Pneumonia, Viral
  • Plasma Exchange
  • Pandemics
  • Myasthenia Gravis
  • Lambert-Eaton Myasthenic Syndrome
  • Immunotherapy
  • Immunosuppressive Agents
  • Immunologic Factors
 

Citation

APA
Chicago
ICMJE
MLA
NLM
International MG/COVID-19 Working Group, ., Jacob, S., Muppidi, S., Guidon, A., Guptill, J., Hehir, M., … Nowak, R. J. (2020). Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci, 412, 116803. https://doi.org/10.1016/j.jns.2020.116803
International MG/COVID-19 Working Group, Richard J., Saiju Jacob, Srikanth Muppidi, Amanda Guidon, Jeffrey Guptill, Michael Hehir, James F. Howard, et al. “Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.J Neurol Sci 412 (May 15, 2020): 116803. https://doi.org/10.1016/j.jns.2020.116803.
International MG/COVID-19 Working Group, Jacob S, Muppidi S, Guidon A, Guptill J, Hehir M, et al. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci. 2020 May 15;412:116803.
International MG/COVID-19 Working Group, Richard J., et al. “Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.J Neurol Sci, vol. 412, May 2020, p. 116803. Pubmed, doi:10.1016/j.jns.2020.116803.
International MG/COVID-19 Working Group, Jacob S, Muppidi S, Guidon A, Guptill J, Hehir M, Howard JF, Illa I, Mantegazza R, Murai H, Utsugisawa K, Vissing J, Wiendl H, Nowak RJ. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci. 2020 May 15;412:116803.
Journal cover image

Published In

J Neurol Sci

DOI

EISSN

1878-5883

Publication Date

May 15, 2020

Volume

412

Start / End Page

116803

Location

Netherlands

Related Subject Headings

  • Vaccines
  • SARS-CoV-2
  • Pneumonia, Viral
  • Plasma Exchange
  • Pandemics
  • Myasthenia Gravis
  • Lambert-Eaton Myasthenic Syndrome
  • Immunotherapy
  • Immunosuppressive Agents
  • Immunologic Factors